Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterisation of COPD heterogeneity in the ECLIPSE cohort.
Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Agusti A, et al. Among authors: miller be. Respir Res. 2010 Sep 10;11(1):122. doi: 10.1186/1465-9921-11-122. Respir Res. 2010. PMID: 20831787 Free PMC article. Clinical Trial.
Evaluation of exhaled breath condensate pH as a biomarker for COPD.
MacNee W, Rennard SI, Hunt JF, Edwards LD, Miller BE, Locantore NW, Tal-Singer R. MacNee W, et al. Among authors: miller be. Respir Med. 2011 Jul;105(7):1037-45. doi: 10.1016/j.rmed.2011.02.009. Epub 2011 Mar 4. Respir Med. 2011. PMID: 21377342 Free article.
COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.
Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators. Dickens JA, et al. Among authors: miller be. Respir Res. 2011 Nov 4;12(1):146. doi: 10.1186/1465-9921-12-146. Respir Res. 2011. PMID: 22054035 Free PMC article. Clinical Trial.
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.
Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, Lomas DA, Duvoix A, MacNee W, Rennard S, Silverman E, Vestbo J, Wouters E, Agustí A; ECLIPSE Investigators. Celli BR, et al. Among authors: miller be. Am J Respir Crit Care Med. 2012 May 15;185(10):1065-72. doi: 10.1164/rccm.201110-1792OC. Epub 2012 Mar 15. Am J Respir Crit Care Med. 2012. PMID: 22427534 Clinical Trial.
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.
Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EF, Celli B; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Polkey MI, et al. Among authors: miller be. Am J Respir Crit Care Med. 2013 Feb 15;187(4):382-6. doi: 10.1164/rccm.201209-1596OC. Epub 2012 Dec 21. Am J Respir Crit Care Med. 2013. PMID: 23262518
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort.
Agusti A, Edwards LD, Celli B, Macnee W, Calverley PM, Müllerova H, Lomas DA, Wouters E, Bakke P, Rennard S, Crim C, Miller BE, Coxson HO, Yates JC, Tal-Singer R, Vestbo J; ECLIPSE Investigators. Agusti A, et al. Among authors: miller be. Eur Respir J. 2013 Sep;42(3):636-46. doi: 10.1183/09031936.00195212. Epub 2013 Jun 13. Eur Respir J. 2013. PMID: 23766334 Free article.
No TWEAK for COPD.
Lazaar AL, Miller BE, Francombe G, Duvoix A, Natanek SA, Polkey MI. Lazaar AL, et al. Among authors: miller be. Eur Respir J. 2013 Oct;42(4):1142-4. doi: 10.1183/09031936.00035413. Eur Respir J. 2013. PMID: 24081764 Free article. No abstract available.
282 results